Meeting a profound unmet need in human therapeutics

Dantari is a Los Angeles area biotechnology company committed to creating breakthrough medicines for the treatment of cancer and other serious diseases.

Using our proprietary platform technology, we have engineered biocompatible polymers that enable targeted delivery of large- and/or small-molecule therapeutics to treat diseases with unmet medical needs.

Our targeting platform provides significantly enhanced capabilities for delivery of therapeutics to treat cancer or diseases in the CNS. The platform also provides differential release kinetics of small-molecule payloads to optimize delivery of the therapeutics.

Dantari scientists are rapidly advancing these therapies to provide meaningful medical improvement for patients.

Our Team

We are scientists and an experienced drug development team committed to leveraging our expertise and diverse backgrounds to advance our technology to benefit patients

Management Team

Richard Markus

Richard Markus, MD, PhD

President and CEO

Emily Wyatt, PhD

Emily Wyatt, PhD

Sr. Director, R&D

Timothy Hagerty, PhD

VP Translational Sciences

Christophe Degois, MBA

Christophe Degois, MBA

VP, Business Development

Gina Knox

Gina Knox, MBA

VP, Business Operations

Mark Henderson, PhD

Mark Henderson, PhD

VP, Manufacturing

Join the team!

Dantari is an Equal Employment Opportunity employer and encourages candidates with diverse backgrounds and experiences to join the team.